Follow
Silvia Basili Franzin
Silvia Basili Franzin
Verified email at uniroma1.it
Title
Cited by
Cited by
Year
N-palmitoyl-D-glucosamine inhibits TLR-4/NLRP3 and improves DNBS-induced colon inflammation through a PPAR-α-dependent mechanism
I Palenca, L Seguella, A Del Re, SB Franzin, C Corpetti, M Pesce, ...
Biomolecules 12 (8), 1163, 2022
112022
Mini-review: interaction between intestinal microbes and enteric glia in health and disease
L Seguella, I Palenca, SB Franzin, A Zilli, G Esposito
Neuroscience Letters 806, 137221, 2023
102023
Oral Immunization with Escherichia coli Nissle 1917 Expressing SARS-CoV-2 Spike Protein Induces Mucosal and Systemic Antibody Responses in Mice
G Sarnelli, A Del Re, M Pesce, J Lu, G Esposito, W Sanseverino, ...
Biomolecules 13 (3), 569, 2023
72023
Miconazole-like Scaffold is a Promising Lead for Naegleria fowleri-Specific CYP51 Inhibitors
V Sharma, VN Madia, V Tudino, JV Nguyen, A Debnath, A Messore, ...
Journal of Medicinal Chemistry 66 (24), 17059-17073, 2023
32023
Intrarectal Administration of Adelmidrol plus Hyaluronic Acid Gel Ameliorates Experimental Colitis in Mice and Inhibits Pro-Inflammatory Response in Ex Vivo Cultured Biopsies …
I Palenca, L Seguella, A Zilli, S Basili Franzin, A Del Re, F Pepi, A Troiani, ...
International Journal of Molecular Sciences 25 (1), 165, 2023
22023
Intranasal delivery of PEA-producing Lactobacillus paracasei F19 alleviates SARS-CoV-2 spike protein-induced lung injury in mice
A Del Re, SB Franzin, J Lu, I Palenca, A Zilli, F Pepi, A Troiani, L Seguella, ...
Translational Medicine Communications 9 (1), 9, 2024
12024
Intranasal administration of Escherichia coli Nissle expressing the spike protein of SARS-CoV-2 induces long-term immunization and prevents spike protein-mediated lung injury …
G Sarnelli, A Del Re, I Palenca, SB Franzin, J Lu, L Seguella, A Zilli, ...
Biomedicine & Pharmacotherapy 174, 116441, 2024
2024
N‐palmitoyl‐d‐glucosamine limits mucosal damage and VEGF‐mediated angiogenesis by PPARα‐dependent suppression of pAkt/mTOR/HIF1α pathway and …
I Palenca, S Basili Franzin, A Zilli, L Seguella, A Troiani, F Pepi, ...
Phytotherapy Research, 2024
2024
Design and synthesis of brain permeable anti-Naegleria fowleri agents targeting CYP51 for primary amoebic meningoencephalitis treatment.
VN Madia, D Ialongo, A Messore, E Patacchini, M Arpacioglu, V Tudino, ...
IX EFMC International Symposium on Advances in Synthetic and Medicinal Chemistry, 2023
2023
Miconazole-like compounds as brain permeable anti-Naegleria Fowleri agents targeting CYP51.
VN Madia, D Ialongo, E Patacchini, A Messore, M Arpacioglu, V Tudino, ...
10th EFMC Young Medicinal Chemists' Symposium, 2023
2023
New blood-brain-barrier permeable compounds as Naegleria Fowleri CYP51 inhibitors.
M Arpacioglu, VN Madia, D Ialongo, E Patacchini, A Messore, V Tudino, ...
XXVIII edition of the National Meeting on Medicinal Chemistry, 2023
2023
PHARMACOGNOSY, PHYTOTHERAPY AND ENTERIC SYSTEM PHARMACOLOGY: INNOVATIVE APPROACHES FOR GREEN PHARMACOLOGICAL STRATEGIES
A Vitalone, A DI SOTTO, S Di Giacomo, M Gullì, E Percaccio, L Seguella, ...
La Facoltà di Farmacia e Medicina presenta le attività di ricerca …, 2023
2023
The system can't perform the operation now. Try again later.
Articles 1–12